Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11261210
APP PUB NO 20150011486A1
SERIAL NO

14377551

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Glycosylated antitumor ether lipids (GAELs) are effective cytotoxic agents against cancer stem cells. Furthermore, combining GAELs which kill cells by a caspase-independent pathway with agents that kill cells by apoptosis will lead to elimination of the differentiated tumor cells and the undifferentiated cancer stem cells leading to an elimination of the tumor and preventing recurrence.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF MANITOBAWINNIPEG MANITOBA R3T 5V4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arthur, Gilbert Winnipeg, CA 5 2
Samadder, Pranati Winnipeg, CA 2 1
Schweizer, Frank Winnipeg, CA 25 65
Xu, Yaozu Winnipeg, CA 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 1, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 1, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 1, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00